Cargando…
Dosing Therapeutic Radiopharmaceuticals in Obese Patients
The prevalence of obesity has increased dramatically in the Western population. Obesity is known to influence not only the proportion of adipose tissue but also physiological processes that could alter drug pharmacokinetics. Yet, there are no specific dosing recommendations for radiopharmaceuticals...
Autores principales: | van Nuland, Merel, Ververs, Tessa F., Lam, Marnix G. E. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775906/ https://www.ncbi.nlm.nih.gov/pubmed/35055005 http://dx.doi.org/10.3390/ijms23020818 |
Ejemplares similares
-
Radiation dose to patients from radiopharmaceuticals
por: Commission Internationale de Protection contre les Radiations
Publicado: (2008) -
Radiation dose to patients from radiopharmaceuticals
por: Commission Internationale de Protection contre les Radiations
Publicado: (1987) -
A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens
por: van der Heijden, Lisa, et al.
Publicado: (2022) -
Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals
por: Ladrière, Typhanie, et al.
Publicado: (2023) -
Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review
por: van der Pol, Jochem, et al.
Publicado: (2017)